<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(7)</volume><submitter>Bomben R</submitter><funding>Associazione Italiana per la Ricerca sul Cancro</funding><funding>Ministero della Salute</funding><funding>Associazione Italiana Contro le Leucemie-Linfomi e Mieloma</funding><journal>HemaSphere</journal><pagination>e128</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11247362</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>CD49d expression is included in a revised 4-factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real-world experience.</pubmed_title><pmcid>PMC11247362</pmcid><funding_grant_id>5x1000</funding_grant_id><funding_grant_id>PNRR‐MAD‐2022‐12375673</funding_grant_id><funding_grant_id>IG‐21687</funding_grant_id><pubmed_authors>Cuneo A</pubmed_authors><pubmed_authors>Martino EA</pubmed_authors><pubmed_authors>Rossi D</pubmed_authors><pubmed_authors>Foa R</pubmed_authors><pubmed_authors>Coscia M</pubmed_authors><pubmed_authors>Trentin L</pubmed_authors><pubmed_authors>Principe MID</pubmed_authors><pubmed_authors>Vit F</pubmed_authors><pubmed_authors>Bittolo T</pubmed_authors><pubmed_authors>Sportoletti P</pubmed_authors><pubmed_authors>Tissino E</pubmed_authors><pubmed_authors>Innocenti I</pubmed_authors><pubmed_authors>Olivieri J</pubmed_authors><pubmed_authors>Vitale C</pubmed_authors><pubmed_authors>Varettoni M</pubmed_authors><pubmed_authors>Pozzo F</pubmed_authors><pubmed_authors>Degan M</pubmed_authors><pubmed_authors>Chiarenza A</pubmed_authors><pubmed_authors>Di Raimondo F</pubmed_authors><pubmed_authors>Gentile M</pubmed_authors><pubmed_authors>Gattei V</pubmed_authors><pubmed_authors>Zucchetto A</pubmed_authors><pubmed_authors>Tafuri A</pubmed_authors><pubmed_authors>Bomben R</pubmed_authors><pubmed_authors>Rossi FM</pubmed_authors><pubmed_authors>Polesel J</pubmed_authors><pubmed_authors>Gaglio A</pubmed_authors><pubmed_authors>Visentin A</pubmed_authors><pubmed_authors>Condoluci A</pubmed_authors><pubmed_authors>Laurenti L</pubmed_authors><pubmed_authors>Marasca R</pubmed_authors><pubmed_authors>Zaja F</pubmed_authors><pubmed_authors>Postorino M</pubmed_authors><pubmed_authors>Del Giudice I</pubmed_authors><pubmed_authors>Mauro FR</pubmed_authors><pubmed_authors>Papotti R</pubmed_authors><pubmed_authors>Laureana R</pubmed_authors><pubmed_authors>Murru R</pubmed_authors><pubmed_authors>Moia R</pubmed_authors><pubmed_authors>Gaidano G</pubmed_authors></additional><is_claimable>false</is_claimable><name>CD49d expression is included in a revised 4-factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real-world experience.</name><description/><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2025-04-25T19:14:39.073Z</modification><creation>2025-04-06T07:54:46.022Z</creation></dates><accession>S-EPMC11247362</accession><cross_references><pubmed>39011128</pubmed><doi>10.1002/hem3.128</doi></cross_references></HashMap>